Navigation Links
Collegium Pharmaceutical's CEO to Present at the Jefferies 2013 Global Health Care Conference in New York on June 4, 2013
Date:5/31/2013

CANTON, Mass., May 31, 2013 /PRNewswire/ -- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that the Company's President and CEO, Michael Heffernan , will present the Company's corporate overview on Tuesday, June 4, 2013 at 3:00pm EDT at the Jefferies 2013 Global Health Care Conference. The conference will be held at the Grand Hyatt New York in New York City.

The Company's lead development program is Oxycodone DETERx®, an abuse-deterrent, extended-release oxycodone product utilizing its proprietary DETERx® technology. The Oxycodone DETERx® formulation was specifically designed to provide and preserve extended release of the active ingredient following the most common methods of product tampering employed by drug abusers (e.g., crushing, chewing, heating for IV injection, etc.). The product is currently in the final stage of clinical development and has been designated Fast Track Status by the FDA due to its potential to address the problem of prescription drug abuse, a major public health issue in the U.S.

About DETERx® Technology

The DETERx® drug delivery platform consists of a multi-particulate matrix formulation in a capsule. While developed primarily to provide abuse-deterrent properties to protect against common methods of tampering such as chewing, crushing, insufflation and extraction for IV injection, the multi-particulate design is expected to enable patients with difficulty swallowing to open the capsule and administer the contents on food or via a gastrostomy tube, while maintaining the extended-release properties of the product. DETERx® technology can be used with drugs that are commonly abused such as opioids and amphetamines, as well as drugs that have narrow therapeutic windows that would benefit from protection against misuse such as breaking, crushing, grinding or dissolving the product. The formulation platform is covered by U.S. and international patents and patent applications. Oxycodone DETERx® is the first of a number of product candidates using the DETERx® platform.

About Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical, Inc. is a specialty pharmaceutical company focused on developing a portfolio of products that incorporate its patent-protected DETERx® formulation platform for the treatment of chronic pain. The DETERx® oral drug delivery technology provides extended release delivery, unique abuse-deterrent properties, and flexible dose administration options. For more information, visit the Company's website at www.collegiumpharma.com.

Contact:

Michael Heffernan , President
Collegium Pharmaceutical, Inc.
781-713-3722
mheffernan@collegiumpharma.com


'/>"/>
SOURCE Collegium Pharmaceutical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Collegium Pharmaceutical to Present at Piper Jaffrays 24th Annual Healthcare Conference
2. Collegium Pharmaceutical Announces Relocation to Massachusetts
3. Collegium Pharmaceuticals CEO to Present at the Cowen & Company 33rd Annual Health Care Conference in Boston on March 6, 2013
4. Collegium Pharmaceutical Names Douglas Carlson to Vice President of Business Development
5. Collegium Announces Results of Chronic Pain Patient Survey - Confirms Significant Unmet Medical Need for a Differentiated, Abuse-Deterrent, Extended-Release Opioid
6. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
7. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
8. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
9. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
10. Icahn Issues Statement Regarding Amylin Pharmaceuticals
11. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2020)... ... , ... At the very heart of Korea's Coronavirus Outbreak is the ... crowded conditions at the church in Daegu, South Korea. There, a parishioner easily spread ... we too have our gathering places where one can expect to meet up with ...
(Date:2/28/2020)... ... February 28, 2020 , ... On Friday, April 17, the ... Recovery Education Classic Golf Tournament. The Phoenix Foundation of Maryland will establish a ... in Frederick, MD. , The golf tournament will host keynote speakers, ...
(Date:2/28/2020)... ... February 27, 2020 , ... zPaper ... in the Salesforce® ecosystem, announced today that its Unified, End-to-End Document and Data ... status demonstrates that the zPaper Document and Data Automation Platform for Salesforce®, with ...
Breaking Medicine Technology:
(Date:2/28/2020)... , ... February 27, 2020 , ... ... Florida and South Carolina conducting Phase I-IV trials, is excited to announce the ... investigating the safety and efficacy of psilocybin for major depressive disorder (MDD). , ...
(Date:2/26/2020)... ... February 26, 2020 , ... The epilepsy ... robotic device that helps pinpoint the origin of epileptic seizures on a patient. ... called a Robotized Surgical Assistant, or ROSA. With assistance from the robot, neurosurgeons ...
(Date:2/23/2020)... , ... February 22, 2020 , ... ... Scene Investigation” Laurence Fishburne ( https://www.imdb.com/name/nm0000401/mediaindex ) is the host of the informational ... large variety of topics affecting people across the country. A soon to be ...
(Date:2/21/2020)... ... ... with Bay-Bay Water today announced that the company has launched a new logo. ... part of the ongoing evolution of our company’s brand,” said Osmay Gonzalez, spokesperson of the ... its national reach. , “We have refreshed our logo to reflect who we are today ...
(Date:2/21/2020)... ... February 21, 2020 , ... Isagenix International ... announced its third and final round of Canada finalists for its annual total-body ... Birr of Markdale, Ontario; Taiya Farrell of Winnipeg, Manitoba; Véronique Collin of Orleans, ...
Breaking Medicine News(10 mins):